CITI PHARMA, a leading pharmaceutical company headquartered in Pakistan, has established itself as a key player in the healthcare industry since its inception in 1994. With a strong operational presence across various regions, the company focuses on the development, manufacturing, and marketing of high-quality pharmaceutical products. CITI PHARMA is renowned for its diverse portfolio, which includes prescription medications, over-the-counter products, and specialised formulations. The company’s commitment to innovation and quality has earned it a reputable position in the market, marked by several key milestones in research and development. With a dedication to improving patient outcomes, CITI PHARMA continues to expand its reach and enhance its product offerings, solidifying its status as a trusted name in the pharmaceutical sector.
How does CITI PHARMA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
CITI PHARMA's score of 22 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
CITI PHARMA, headquartered in Pakistan (PK), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Consequently, there are no documented Scope 1, 2, or 3 emissions to analyse. In terms of climate commitments, CITI PHARMA has not established any formal reduction targets or initiatives, nor have they made any climate pledges. This lack of data suggests that the company may still be in the early stages of developing a comprehensive climate strategy. As the industry increasingly prioritises sustainability, CITI PHARMA's future efforts in carbon emissions reduction and climate action will be crucial for aligning with global standards and expectations.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
CITI PHARMA has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
